IP Library Granted Patent US 9,546,388
Granted Patent B2
US 9,546,388 · App. 14/710,893 · Granted Jan 17, 2017

Variant LovD polypeptides and their uses

Inventors: Lynne Gilson (Encinitas, CA); Steven J. Collier (Concord, MA); Joly Sukumaran (Singapore, SG); Wan Lin Yeo (Singapore, SG); Oscar Alvizo (Fremont, CA); Ee Ling Teo (Mauchline East Ayrshire, GB); Robert J. Wilson (San Francisco, CA); Junye Xu (Singapore, SG)
Assignee: Codexis, Inc.
C12P17/06C07K14/00C12N9/1025C12N9/1029C12P7/62Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,546,388
App. No.
14/710,893
Granted
Jan 17, 2017
Kind
B2
Abstract

The present disclosure provides acyltransferases useful for synthesizing therapeutically important statin compound.

Claims (10)

1. A method of making simvastatin comprising contacting monacolin J or lovastatin substrate with a variant LovD polypeptide having at least 90% sequence identity to the wild-type Aspergillus terreus acyltransferase of SEQ ID NO:2, wherein said variant comprises the substitution L361M and from 1 to 30 additional substitutions, and wherein said contacting is conducted in the presence of an α-dimethylbutyryl thioester co-substrate and under conditions in which simvastatin is produced.

2. The method of claim 1 , wherein the monacolin J is a sodium salt.

3. The method of claim 2 , wherein the monacolin J is a sodium salt and activated charcoal is added.

4. The method of claim 1 , wherein the monacolin J is an ammonium salt.

5. The method of claim 4 , wherein an agent for precipitating simvastatin is added.

6. The method of claim 5 , wherein said agent is ammonium hydroxide.

7. The method of claim 1 , wherein said lovastatin substrate, said variant LovD polypeptide and said thioester are added at substantially the same time into a vessel.

8. The method of claim 7 , wherein said lovastatin substrate and said variant LovD polypeptide are first added into a vessel and then said thioester is added into said vessel.

9. The method of claim 1 , wherein an agent for precipitating simvastatin is added.

10. The method of claim 9 , wherein said agent is ammonium hydroxide.

Assignments (1)
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →
Continuity (6)
Division 14465467 · Aug 21, 2014
Division 13755113 · Jan 31, 2013
Division 12890134 · Sep 24, 2010
Provisional Application 61247253 · Sep 30, 2009
Provisional Application 61247274 · Sep 30, 2009
Related Publication 20150240276A1 · Aug 27, 2015